Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Viagra Patent Ruling Could Deter Appeal, Support Pfizer Position In Pending Cases

Executive Summary

Teva Pharmaceuticals USA Inc. is considering whether to appeal a federal court decision upholding the validity of Pfizer Inc.'s Viagra (sildenafil) patent.
Advertisement

Related Content

Regeneron's Patent Pratfall: First Inequitable Conduct, Now Possible Sanctions
Teva’s Generic Viagra Launch Will Be Offset By Generic Cialis
Viagra’s End Begins: Generic Sildenafil Launches For Revatio
Inequitable Conduct "Plague" Cured By Federal Circuit's Therasense Decision
Inequitable Conduct "Plague" Cured By Federal Circuit's Therasense Decision

Topics

Advertisement
UsernamePublicRestriction

Register

PS053726

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel